Login to Your Account



Amgen Earnings Up 14 Percent As Phase III NESP Trial Begins


Friday, July 24, 1998
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription